Category:
Description:
Indications:
-
Lower respiratory tract infections (S.
pneumoniae, S. pyogenes and other streptococci, H.
influenzae, Klebsiella species, S. aureus, E. coli,H. influenzae, H. parainfluenzae, Serratia
marcescens, Enterobacter species, P. mirabilis)
-
Urinary tract infections (Enterococcus species, S.
aureus, S. epidermidis, Citrobacter sepcies, Enterobacter species, E. coli,
Klebsiella species, P.
mirabilis, P. vulgaris, P. inconstans group B, Providencia rettgeri, Morganella morganii, S. marcescens, Pseudomonas species)
-
Uncomplicated gonorrhea (N. gonorrhoeae)
-
Gynecological infections (S. epidermidis, streptococci, Enterococcus, Enterobacter species, E.
coli, Klebsiella species,P.
mirabilis, Bacteroides species,
Clostridium species, anaerobic
cocci (Peptococcus and Peptostreptococcus), Fusobacterium species)
-
Intra-abdominal infections (E. coli, S. epidermidis, Streptococcus species, Enterobacter species, Klebsiella species, Bacteroides species, Peptococcus and Peptostreptococcus species)
-
Bacteremia/septicemia (Klebsiella species, E. coli,
S. marcescens, S. aureus, streptococci)
-
Skin, bone and joint infections (S. aureus, S. epidermidis, S. pyogenes, Actinetobacter species, E.
coli, Citrobacter species, Klebsiella species, M.
morganii, P. mirabilis, S. marcescens, P.
rittgeri, P. vulgaris, Pseudomonas species, Enterococcus, Enterobacter, Bacteriodes species and anaerobic cocci
(including Peptococcus and Peptostreptococcus species))
-
CNS infections/meningitis (H. influenzae, N. meningitidis, S. pneumoniae, K. pneumoniae, E. coli)
Contraindications:
Precautions:
Adverse
Reactions (Side Effects):
-
Hypersensitivity
reactions
-
Gastrointestinal:
nausea, vomiting, diarrhea
-
Vaginitis
|
Dosage:
-
Administered
by injection (IM and IV)
-
Adults:
-
gonococcal urethritis/cervicitis:
-
rectal gonorrhea (female):
-
rectal gonorrhea (male):
-
uncomplicated infections:
-
moderate to severe infections:
-
other sites
-
infections generally requiring high dose
(septicemia):
-
life-threatening infections:
-
peri-operative prophylaxis:
-
Cesarean section:
-
Child (0-1 week)
-
Child (1-4 weeks)
-
Child (1 month – 12 years)
|
|
|
|
The information contained here is an
abbreviated summary. For more detailed and complete information, consult the
manufacturer's product information sheets or standard textbooks
Source: Operational Medicine 2001, Health
Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau
of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington,
D.C., 20372-5300
This information is provided by The Brookside Associates. The Brookside
Associates, LLC. is a private organization, not affiliated with any governmental
agency. The opinions presented here are those of the author and do not
necessarily represent the opinions of the Brookside Associates or the Department
of Defense. The presence of any advertising on these pages does not constitute
an endorsement of that product or service by either the US Department of Defense
or the Brookside Associates. All material presented here is unclassified.
C. 2009, 2014, All Rights Reserved
|
|